Pharmacy First scheme expands but faces £2.5bn funding crisis

The Pharmacy First scheme in England has seen rapid growth since its launch in early 2024. Between March 2025 and February 2026, pharmacists carried out over 3.3 million consultations under the programme. Despite this success, leaders in the sector warn that financial pressures remain a major concern. The scheme was introduced to ease pressure on GP surgeries and emergency departments by allowing community pharmacies to treat minor illnesses. Currently, pharmacists can prescribe medicines for seven common conditions, including infections and skin complaints. They also offer services like blood pressure checks, contraception advice, and treatment for eye, ear, mouth, and digestive issues.

From autumn 2026, the programme will expand further. A £340 million investment will add five more conditions to the list of treatable ailments. Additionally, all newly trained pharmacists will qualify as independent prescribers as part of their standard education.

However, funding remains a critical issue. The National Pharmacy Association estimates a £2.5 billion shortfall in community pharmacy budgets. Dr Leyla Hannbeck, chief executive of the Independent Pharmacies Association, has raised concerns about whether the new funding is enough to support the reforms. The expansion of Pharmacy First aims to increase access to healthcare while reducing strain on other NHS services. Yet, with a reported £2.5 billion funding gap, the sector faces ongoing challenges in delivering these extended services. The success of the scheme will depend on balancing growing demand with financial sustainability.